Clinical Trial Update: Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose pharmacokinetics study of tolvaptan tablets conducted in Chinese patients with hepatic cirrhosis and ascites; the trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Hepatic Cirrhosis

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Hepatic Cirrhosis, Ascites | Phase 1 | Status: COMPLETED